90 related articles for article (PubMed ID: 9231354)
1. A sensitive assay for studying dopaminergic activity in cultures of rat pituitary cells.
Giacomelli S; Braghiroli L; Ponzianelli A; Koppenaal DW; De Feo G
J Pharm Pharmacol; 1997 Mar; 49(3):319-21. PubMed ID: 9231354
[TBL] [Abstract][Full Text] [Related]
2. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
Giacomelli S; Palmery M; Romanelli L; Cheng CY; Silvestrini B
Life Sci; 1998; 63(3):215-22. PubMed ID: 9698051
[TBL] [Abstract][Full Text] [Related]
3. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape.
Arita J; Hashi A; Hoshi K; Mazawa S; Suzuki S
Neuroendocrinology; 1998 Sep; 68(3):163-71. PubMed ID: 9734000
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Cho S; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
[TBL] [Abstract][Full Text] [Related]
5. Modulation by dopamine antagonists of DNA synthesis in the pituitary gland of the male rat.
Jacobi JM; Lloyd HM
Neuroendocrinology; 1981 Aug; 33(2):97-100. PubMed ID: 7266775
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2007 Dec; 195(2):213-22. PubMed ID: 17668188
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic modulation of nNOS expression in the pituitary gland of male rat.
Carretero J; Weruaga E; Hernández E; Burks D; Riesco JM; Rubio M; Briñón JG; Aijón J; Vázquez R; Alonso JR
Anat Embryol (Berl); 2003 Dec; 207(4-5):381-8. PubMed ID: 14618399
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat.
Millington WR; O'Donohue TL; Mueller GP
J Pharmacol Exp Ther; 1987 Oct; 243(1):160-70. PubMed ID: 2959768
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.
Sands SA; Dickerson DS; Morris SJ; Chronwall BM
Endocrine; 1997 Jun; 6(3):325-33. PubMed ID: 9368690
[TBL] [Abstract][Full Text] [Related]
10. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
Mittleman G; Rosner AL; Schaub CL
J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats.
Gao X; Zhang Y; Wu G
Eur J Pharmacol; 2001 Apr; 418(1-2):73-7. PubMed ID: 11334867
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
O'Neill MJ; Hicks CA; Ward MA; Cardwell GP; Reymann JM; Allain H; Bentué-Ferrer D
Eur J Pharmacol; 1998 Jul; 352(1):37-46. PubMed ID: 9718265
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells.
Dwyer DS; Liu Y; Bradley RJ
Neurosci Lett; 1999 Oct; 274(3):151-4. PubMed ID: 10548412
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK
Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopaminergic agents on carrageenan hyperalgesia in rats.
Gao X; Zhang Y; Wu G
Eur J Pharmacol; 2000 Oct; 406(1):53-8. PubMed ID: 11011033
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic stimulation of prolactin release.
Denef C; Manet D; Dewals R
Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
[TBL] [Abstract][Full Text] [Related]
17. D2 and D1 dopaminergic activity of 7-OH-DPAT.
Sethy VH; Ellerbrock BR; Fici GJ; Wu H
Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
George B; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):481-8. PubMed ID: 9413831
[TBL] [Abstract][Full Text] [Related]
19. D1 dopamine receptor activity of anti-parkinsonian drugs.
Fici GJ; Wu H; VonVoigtlander PF; Sethy VH
Life Sci; 1997; 60(18):1597-603. PubMed ID: 9126882
[TBL] [Abstract][Full Text] [Related]
20. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
